Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cancers With DNA Repair-Deficiency × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 25 Breast Neoplasms 16 Neoplasms 9 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Sarcoma 5 Pancreatic Neoplasms 5 Fanconi Anemia, Complementation Group D1 5 Endometrial Neoplasms 5 Small Cell Lung Carcinoma 4 Recurrence 4 Colorectal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Metastatic Castration-resistant Prostate Cancer 2 Glioma 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Solid Tumours 2 Advanced Solid Tumors 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Solid Tumor 1

Interventions

olaparib 1 Trabectedin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03127215 2024-05-08

NCT-PMO-1603

National Center for Tumor Diseases, Heidelberg

Phase 2 Completed

Cancers With DNA Repair-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡